MedTrace Logo

Efficacy and Safety of Eyetronix Flicker Glasses to the Treatment of Anisometropic Amblyopia

NCT02970708 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2016-11-22

No results posted yet for this study

Summary

To evaluate the efficacy and safety of Eyetronix Flicker Glassess therapy in treating anisometropic amblyopia.

Conditions

  • Amblyopia, Anisometropic

Interventions

DEVICE

EFG group

88 anisometropic amblyopia will be recruited to receive Eyetronix Flicker Glasses treatment.

DEVICE

Patching group

88 anisometropic amblyopia will be recruited to receive patching treatment.

Sponsors & Collaborators

  • Shanghai Eye Disease Prevention and Treatment Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-06-30
Completion
2020-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02970708 on ClinicalTrials.gov